Table 1.
Study characteristic of the BaSAlt cohort with group comparison for sarcopenia quantification, and Spearman correlation coefficients by PhA
| Degree of care Md (range) mean ± SD | Age (in years) Md (range) mean ± SD | Height (in cm) Md (range) mean ± SD |
Weight (in kg) Md (range) mean ± SD | BMI (in kg/m2) Md (range) mean ± SD | Number of morbidities Md (range) mean ± SD |
BI (in points) Md (range) mean ± SD | MMST (in points) Md (range) mean ± SD | MNA-SF® (in points) Md (range) mean ± SD | |
|---|---|---|---|---|---|---|---|---|---|
|
No sarcopenia ngroup = 32 nfemale = 25 nmale = 7 |
3.0 (2–4) 2.94 ± 0.76 |
86.0 (65–98) 87.28 ± 7.20 |
162.5 (150.0–175.0) 172,75 ± 7.22 |
68.6 (41.4–101.0) 68.21 ± 11.22 |
25.0 (17.5–43.1) 25.81 ± 4.55 |
3.0 (1–5) 3.13 ± 1.16 |
80.0 (15–100) 73.28 ± 23.34 |
23.5 (4–30) 21.32 ± 7.45 |
12.0 (9–14) 12.10 ± 1,64 |
|
Probable sarcopenia ngroup = 33 nfemale = 21 nmale = 12 |
3.0 (2–4) 3.00 ± 0.61 |
87.0 (64–94) 85.67 ± 6.87 |
165.0 (144.0–187.0) 165.06 ± 9.02 |
73.1 (53.1–111.0) 75.72 ± 15.86 |
25.9 (20.9–45.4) 27.82 ± 5.65 |
3.0 (1–10) 3.53 ± 1.87 |
65.0 (10–100) 61.82 ± 22.74 |
19.0 (0–30) 19.26 ± 7.94 |
12.0 (8–14) 11.85 ± 156 |
|
Confirmed/ severe sarcopenia ngroup = 13 nfemale = 12 | nmale = 1 |
3.0 (2–4) 3.08 ± 0.64 |
89.0 (71–97) 89.15 ± 6.40 |
152.0 (140.0–174.0) 154.62 ± 10.20 |
57.4 (36.4–70.2) 54.96 ± 9.80 |
23.6 (15.5–28.9) 22.92 ± 3.42 |
2.0 (0–6) 2.85 ± 2.04 |
60.0 (25–75) 54.23 ± 16.69 |
15.0 (9–27) 17.73 ± 6.57 |
11.5 (3–13) 10.08 ± 3.15 |
| Kruskal-Wallis-test | H = 0.427, p = 0.808 | H = 3.400, p = 0.183 | H = 10.899, p = 0.004* | H = 19.193, p < 0.001* | H = 9.681, p = 0.008* | H = 1.106, p = 0.575 | H = 10.919, p = 0.004* | H = 2.400, p = 0.301 | H = 4.795, p = 0.091 |
| Dunn–Bonferroni-post-hoc-tests | |||||||||
| No sarcopenia –probable sarcopenia | – | – | z = − 0.992, p = 0.964 | z = − 1.751, p = 0.240 | z = − 1.337, p = 0.543 | – | z = 2.337, p = 0.058 | – | – |
| No sarcopenia –confirmed, severe sarcopenia | – | – | z = 2.529, p = 0.034* | z = 3.039, p = 0.007* | z = 2.083, p = 0.112 | – | z = 1.296, p = 0.585 | – | – |
| Probable sarcopenia –confirmed, severe sarcopenia | – | – | z = 3.292, p = 0.003* | z = 4.379, p < 0.001* | z = 3.105, p = 0.006* | – | z = 3.053, p = 0.007* | – | – |
| Spearman correlation with PhA | r = 0.190, p = 0.095 | r = − 0.245, p = 0.031* | r = 0.088, p = 0.442 | r = − 0.089, p = 0.436 | r = − 0.048, p = 0.676 | r = − 0.084, p = 0.468 | r = − 0.080, p = 0.487 | r = − 0.140, p = 0.264 | r = − 0.015, p = 0.896 |
BI Barthel-index, BMI body-mass-index, mini-mental-status-test, MNA-SF® mini-nutrition-assessment-short-form
Essential is the indication of the p-values in italics, which are additionally marked as significant with a *
*Significant result for p ≤ 0.05 (two-sided test)